Probio-X improved blood lipid indexes in a hyperlipidemia population.
hyperlipidemia
HYPERLIPIDEMIA
Body weight, height, and work employment were collected and analyzed (Information of patientsThere were no significant differences in all blood biochemistry between the placebo and probiotic groups at baseline. The blood analysis of hyperlipidemic patients showed that the total cholesterol (TC) and low-density lipoprotein (LDL-C) levels decreased significantly after probiotic consumption (paired Probio-X improved blood lipid indexes in hyperlipidemia patients. (A) Comparative analysis of (A) blood indicators; (B) body weight and composition; (C) gut mucosa indicators. (D) Number of patients that were responsive toward probiotic treatment, evaluated by changes in four key blood lipid indicators. Chi-square test was performed to evaluate the overall difference between two groups. LDL-C, low-density lipoprotein; TC, total cholesterol; HDL-C, high-density lipoprotein; TG, triglyceride; *, We further analyzed changes in the four main blood lipid indicators in the placebo and probiotic groups (